Anebulo Pharmaceuticals, Inc. (ANEB): Price and Financial Metrics
ANEB Price/Volume Stats
| Current price | $1.52 | 52-week high | $3.30 |
| Prev. close | $1.52 | 52-week low | $1.46 |
| Day low | $1.51 | Volume | 3,700 |
| Day high | $1.66 | Avg. volume | 6,692 |
| 50-day MA | $1.89 | Dividend yield | N/A |
| 200-day MA | $2.31 | Market Cap | 39.42M |
ANEB Stock Price Chart Interactive Chart >
Anebulo Pharmaceuticals, Inc. (ANEB) Company Bio
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients suffering from cannabinoid overdose and addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.
ANEB Price Returns
| 1-mo | -17.41% |
| 3-mo | -27.27% |
| 6-mo | -28.13% |
| 1-year | -27.96% |
| 3-year | -77.17% |
| 5-year | N/A |
| YTD | -37.19% |
| 2023 | -0.15% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...